机构:[a]Spine Department, Foshan Hospital of Traditional Chinese Medicine, Foshan, Guangdong , P.R. China[b]Spine Department, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong , P.R. China
We showed that miR-107 expression was decreased in osteosarcoma (OS) tissues and cell lines. miR-107 mimic significantly decreased OS cell proliferation and inhibited invasion and migration of OS cells. Inhibition of miR-107 expression notably promoted proliferation, invasion and migration of OS cells. In addition, miR-107 mimic inhibited EMT biomarkers and significantly increased apoptosis. miR-107 mimic significantly decreased the protein expression of β-catenin, Cyclin D1, and c-Myc, whereas increased GSK-3β protein expression. miR-107 mimic markedly reduced the luciferase activity of 3'UTR of β-catenin. Overexpression of β-catenin inhibited miR-107 mimic-induced decrease of cell proliferation, invasion and migration ability, and increase of apoptosis.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类|3 区医学
小类|4 区肿瘤学
最新[2025]版:
大类|4 区医学
小类|4 区肿瘤学
第一作者:
第一作者机构:[a]Spine Department, Foshan Hospital of Traditional Chinese Medicine, Foshan, Guangdong , P.R. China
通讯作者:
通讯机构:[a]Spine Department, Foshan Hospital of Traditional Chinese Medicine, Foshan, Guangdong , P.R. China[*1]Spine Department, Foshan Hospital of Traditional Chinese Medicine, Foshan, Guangdong 528000, P.R. China.
推荐引用方式(GB/T 7714):
Miao Yu,Danqing Guo,Zhenglin Cao,et al.Inhibitory Effect of MicroRNA-107 on Osteosarcoma Malignancy Through Regulation of Wnt/β-catenin Signaling in Vitro.[J].Cancer investigation.2018,36(3):175-184.doi:10.1080/07357907.2018.1439055.
APA:
Miao Yu,Danqing Guo,Zhenglin Cao,Longyi Xiao&Gang Wang.(2018).Inhibitory Effect of MicroRNA-107 on Osteosarcoma Malignancy Through Regulation of Wnt/β-catenin Signaling in Vitro..Cancer investigation,36,(3)
MLA:
Miao Yu,et al."Inhibitory Effect of MicroRNA-107 on Osteosarcoma Malignancy Through Regulation of Wnt/β-catenin Signaling in Vitro.".Cancer investigation 36..3(2018):175-184